— Know what they know.
Not Investment Advice

002437.SZ SHZ

Harbin Gloria Pharmaceuticals Co., Ltd
1W: -3.4% 1M: -16.5% 3M: +24.1% YTD: +4.9% 1Y: +2.8% 3Y: +78.9% 5Y: +43.1%
¥3.65 ($0.54)
+0.18 (+5.19%)
 
SHZ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 37 · ¥8.1B mcap · 1.60B float · 15.63% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap¥8.1B ($1.2B)
52W Range2.37-5.1
Volume357,090,907
Avg Volume249,975,762
Beta0.09
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOLeifeng Guo
Employees2,350
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2011-10-27
Websitegloria.cc
No. 29, Beijing Road
Harbin 150025
CN
86 451 5735 1368
About Harbin Gloria Pharmaceuticals Co., Ltd

Harbin Gloria Pharmaceuticals Co., Ltd. is a Chinese pharmaceutical enterprise primarily focused on the research, development, manufacturing, and commercialization of various medicinal products within the People's Republic of China. The company's comprehensive portfolio addresses a broad spectrum of therapeutic areas, including cardiac and cerebrovascular health, skeletal muscle system support, and urinary tract conditions. It also provides vitamins and minerals, as well as medications for oncology, endocrine disorders, anti-infective treatments, respiratory ailments, antihistamine purposes, and peptic concerns, among other pharmaceutical goods. Established in 2000, the firm's headquarters are located in Harbin, also situated in the People's Republic of China.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms